Primary Recipient

OSEL, INC.

Amount

$425,654.00

Award Date

9/29/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Project Narrative Osel, Inc. is developing a live microbicide by employing a human vaginal isolate of hydrogen peroxideproducing Lactobacillus jensenii that has been genetically modified to constitutively secrete high levels of a potent HIV entry inhibito